By Peter Loftus

New Covid-19 vaccine booster shots are coming to a pharmacy near you after U.S. health officials cleared them Wednesday. But who gets access to the shots, at a time when infections are rising in many states, may be more limited than previous years because of the Trump administration's narrower approval.

The Food and Drug Administration authorized three new Covid-19 vaccines -- from Pfizer and its partner BioNTech, and Moderna and Novavax -- that target a variant of the coronavirus known as LP.8.1. This was the dominant circulating strain when FDA advisers picked a target in May.

The companies are expected to begin shipping doses to pharmacies and other vaccination sites within days. This is the fourth year companies have updated Covid shots to target the primary variant that is circulating, in hopes the shots will better protect people from severe illness through the fall and winter months.

This is a developing story.

(END) Dow Jones Newswires

August 27, 2025 13:12 ET (17:12 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.